A new long-acting contraceptive designed to be self-administered by women may provide a new family planning option, particularly in developing nations where access to health care can be limited, a recent study suggests. The contraceptive would be delivered using microneedle skin patch technology originally developed for the painless administration of vaccines.
In February 2013, the U-M Medical School was awarded $2.4 million to help fund the U-M Michigan Translational Research and Commercialization for Life Sciences Program (U-M MTRAC). Of the 39 proposals submitted in its first year, the MTRAC Oversight Committee selected 11 for funding, including one by Dr. Anna Schwendeman, Assistant Professor of Medicinal Chemistry at the College of Pharmacy.
College of Pharmacy faculty members Dr. Vicki Ellingrod, John Gideon Searle Professor of Pharmacy and Associate Chair for Research Development and Mentorship in the Department of Clinical, Social, and Administrative Sciences, and Dr. Kathleen Stringer, Professor of Pharmacy in the Department of Clinical, Social and Administrative Sciences, received a supplemental grant from the National Institutes of Health (NIH).